SOLIGENIX, INC.

For the period ended Dec 31, 2025. Filed Mar 31, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 31, 2026

SNGX$0.34+0.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item	Description	Page
Cautionary Note Regarding Forward-Looking Statements · · ii
	Part I
1.	Business	1
1A.	Risk Factors	29
1B.	Unresolved Staff Comments	53
1C	Cybersecurity	53
2.	Properties	54
3.	Legal Proceedings	54
	Part II
5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	55
6.	Selected Financial Data	55
7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	56
8.	Financial Statements and Supplementary Data	65
9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	65
9A.	Controls and Procedures	65
9B.	Other Information	66
9C.	Disclosure Regarding Foreign Jurisdictions	66
	Part III
10.	Directors, Executive Officers and Corporate Governance	66
11.	Executive Compensation	71
12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	76
13.	Certain Relationships and Related Transactions and Director Independence	78
14.	Principal Accountant Fees and Services	79
	Part IV
15.	Exhibits and Financial Statement Schedules	80
Signatures	85
Consolidated Financial Statements	F-1

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents